Clinical Trial Application (CTA) documents filed – another significant TOPADUR milestone to our first clinical study !

Dear TOPADUR followers,

We are proud to announce that another important milestone of our dynamic young start-up was achieved on May 11, 2020. The application documents (Clinical Trial Application – CTA) for approval of our phase 1 study for diabetic foot ulcer (DFU) have been submitted to the authorities and the ethics committee.